Search through
Etoricoxib API (CAS 202409-33-4) is a selective COX-2 inhibitor widely used in pharmaceutical manufacturing for anti-inflammatory and analgesic formulations. Known for its targeted mechanism of action, it inhibits cyclooxygenase-2 to reduce pain and inflammation while maintaining a favorable gastrointestinal profile compared to traditional NSAIDs. Manufactured through controlled multi-step organic synthesis, etoricoxib is supplied as a high-purity crystalline powder (99% purity) with consistent impurity profiling and batch-to-batch reproducibility. As a trusted etoricoxib supplier in the USA, we offer high-quality API with reliable sourcing, scalable volumes, and complete technical documentation including COA, SDS, and DMF support. Our supply chain is designed to support pharmaceutical companies, CDMOs, and formulation developers in the USA with consistent quality, regulatory-ready material, and dependable performance for commercial manufacturing.
Etoricoxib API (CAS 202409-33-4) is a selective COX-2 inhibitor widely used in pharmaceutical manufacturing for anti-inflammatory and analgesic formulations. Known for its targeted mechanism of action, it inhibits cyclooxygenase-2 to reduce pain and inflammation while maintaining a favorable gastrointestinal profile compared to traditional NSAIDs. Manufactured through controlled multi-step organic synthesis, etoricoxib is supplied as a high-purity crystalline powder (99% purity) with consistent impurity profiling and batch-to-batch reproducibility. As a trusted etoricoxib supplier in the USA, we offer high-quality API with reliable sourcing, scalable volumes, and complete technical documenta...
.3d8f8f41.svg)
Pharmaceutical
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Active Pharmaceutical Ingredients (APIs)
.7767eb0f.png)
Chemical Properties & Specifications
H302, H315, H319, H335
P264, P270, P301 + P312, P305 + P351 + P338
Category 2, 3, 2A, 4
Health Hazards: Harmful by ingestion, may cause respiratory irritation, skin, and eye irritation
WGK 2 (Class 2: hazardous to water)
Etoricoxib API is widely used in the development and manufacturing of tablets for anti-inflammatory and analgesic therapies, supporting formulation teams working on stable, high-bioavailability oral dosage forms.
Used by formulation scientists and CDMOs during process optimization, bioequivalence studies, and scale-up manufacturing, where consistent impurity profiles and particle size distribution are critical.
Etoricoxib API is sourced by contract manufacturers supporting global pharmaceutical programs, enabling efficient batch production, process validation, and commercial manufacturing workflows.
Utilized in the development of combination therapies with other analgesics or supportive APIs, where selective COX-2 inhibition is required alongside complementary mechanisms of action.
Applied in stability testing, analytical method development, and dossier preparation, where reproducibility, documentation (DMF/COA), and compliance with ICH guidelines are essential for regulatory submissions.
Store at 20–25°C (68–77°F)
Keep in a cool, dry place away from light and moisture
Use airtight containers to prevent contamination and degradation
13 - Non-combustible solids